Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Dev Med Child Neurol ; 63(2): 135-143, 2021 02.
Article in English | MEDLINE | ID: mdl-33084055

ABSTRACT

Prenatal infections have long been recognized as important, preventable causes of developmental disabilities. The list of pathogens that are recognized to have deleterious effects on fetal brain development continues to grow, most recently with the association between Zika virus (ZIKV) and microcephaly. To answer clinical questions in real time about the impact of a novel infection on developmental disabilities, an historical framework is key. The lessons learned from three historically important pathogens: rubella, cytomegalovirus, and ZIKV, and how these lessons are useful to approach emerging congenital infections are discussed in this review. Congenital infections are preventable causes of developmental disabilities and several public health approaches may be used to prevent prenatal infection. When they cannot be prevented, the sequelae of prenatal infection may be treatable. WHAT THIS PAPER ADDS: The list of prenatal infections associated with developmental disabilities continues to increase. Lessons learned from rubella, cytomegalovirus, and Zika virus have implications for new pathogens. Severity of illness in the mother does not correlate with severity of sequelae in the infant.


Subject(s)
Cytomegalovirus Infections , Developmental Disabilities , Fetal Diseases , Pregnancy Complications, Infectious , Rubella , Zika Virus Infection , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/history , Cytomegalovirus Infections/therapy , Developmental Disabilities/etiology , Developmental Disabilities/history , Developmental Disabilities/prevention & control , Female , Fetal Diseases/history , Fetal Diseases/therapy , History, 20th Century , History, 21st Century , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/history , Pregnancy Complications, Infectious/therapy , Rubella/complications , Rubella/congenital , Rubella/history , Rubella/therapy , Zika Virus Infection/complications , Zika Virus Infection/congenital , Zika Virus Infection/history , Zika Virus Infection/therapy
2.
Curr Opin Allergy Clin Immunol ; 20(6): 574-581, 2020 12.
Article in English | MEDLINE | ID: mdl-33044342

ABSTRACT

PURPOSE OF THE REVIEW: The aim of this article is to summarize recent data on rubella virus (RuV) vaccine in chronic inflammation focusing on granulomas in individuals with primary immunodeficiencies (PIDs). RECENT FINDINGS: The live attenuated RuV vaccine has been recently associated with cutaneous and visceral granulomas in children with various PIDs. RuV vaccine strain can persist for decades subclinically in currently unknown body site(s) before emerging in granulomas. Histologically, RuV is predominately localized in M2 macrophages in the granuloma centers. Multiple mutations accumulate during persistence resulting in emergence of immunodeficiency-related vaccine-derived rubella viruses (iVDRVs) with altered immunological, replication, and persistence properties. Viral RNA was detected in granuloma biopsies and nasopharyngeal secretions and infectious virus were isolated from the granuloma lesions. The risk of iVDRV transmissibility to contacts needs to be evaluated. Several broad-spectrum antiviral drugs have been tested recently but did not provide significant clinical improvement. Hematopoietic stem cell transplantation remains the only reliable option for curing chronic RuV-associated granulomas in PIDs. SUMMARY: Persistence of vaccine-derived RuVs appears to be a crucial factor in a significant proportion of granulomatous disease in PIDs. RuV testing of granulomas in PID individuals might help with case management.


Subject(s)
Granuloma/immunology , Hematopoietic Stem Cell Transplantation , Inflammation/immunology , Primary Immunodeficiency Diseases/immunology , Rubella virus/physiology , Rubella/immunology , Viral Vaccines/immunology , Adolescent , Child , Chronic Disease , Granuloma/complications , Granuloma/therapy , Humans , Inflammation/complications , Inflammation/therapy , Primary Immunodeficiency Diseases/complications , Primary Immunodeficiency Diseases/therapy , Rubella/complications , Rubella/therapy , Sexually Transmitted Diseases, Viral , Vaccines, Attenuated
3.
Invest Ophthalmol Vis Sci ; 60(7): 2399-2405, 2019 06 03.
Article in English | MEDLINE | ID: mdl-31157832

ABSTRACT

Purpose: To investigate the clinical and virologic-associated and predictive factors of intraocular pressure (IOP) evolution over time and its severity in Fuchs' heterochromic iridocyclitis (FHC). Methods: Consecutive patients with both clinical FHC and intraocular synthesis of rubella virus (RV)-specific antibodies were included in this study. Specific ocular production of RV antibodies was confirmed using the quotient of serum/aqueous humor ratio of RV IgGs (Crv) and control antiviral IgGs (Cctl), using quantitative serology methods. Epidemiologic, clinical, biological, and virologic data at referral were collected and correlated with IOP values over time, occurrence, and severity of glaucoma. Results: Sixty-eight eyes of 68 patients were included. Mean age at diagnosis was 40.7 ± 11.1 years. Mean follow-up was 4.3 ± 4.3 years. Mean baseline Crv and Cctl values were 12.34 ± 14.67 and 216.70 ± 98.4, respectively. Mean baseline IOP was 17.2 ± 7.2 mm Hg (range, 9-40) and 15.6 ± 5.6 (range, 3-30) 5 years after referral. The predictive factors for pejorative IOP evolution over time and glaucoma severity were male sex (P = 0.03) and decreased Crv (P = 0.04) and presence of iris nodules (P < 0.001) and decreased Cctl (P = 0.02), respectively. Diagnostic delay was associated with increased likelihood of undergoing glaucoma surgery (P = 0.02). Conclusions: Time to diagnosis, male sex, presence of iris nodules at baseline, and decreased Crv and Cctl ratios were associated with increased likelihood of pejorative IOP evolution over time. Given the aggressiveness of glaucoma in FHC, these results provide interesting insight into what category of patients should need the closest screening.


Subject(s)
Eye Infections, Viral/diagnosis , Glaucoma, Open-Angle/diagnosis , Intraocular Pressure/physiology , Iridocyclitis/diagnosis , Rubella virus/immunology , Rubella/diagnosis , Adult , Aged , Antibodies, Viral/blood , Antihypertensive Agents/therapeutic use , Aqueous Humor/virology , Eye Infections, Viral/immunology , Eye Infections, Viral/physiopathology , Female , Filtering Surgery , Follow-Up Studies , Glaucoma, Open-Angle/physiopathology , Glaucoma, Open-Angle/therapy , Humans , Iridocyclitis/immunology , Iridocyclitis/physiopathology , Male , Middle Aged , Retrospective Studies , Rubella/physiopathology , Rubella/therapy , Severity of Illness Index , Time Factors , Tonometry, Ocular , Young Adult
4.
Hum Vaccin Immunother ; 13(8): 1952-1955, 2017 08 03.
Article in English | MEDLINE | ID: mdl-28604142

ABSTRACT

Rubella antibodies are not routinely measured in immunoglobulin products and there is a lack of information on the titer in Australian products. To facilitate future studies of the effectiveness of passive immunisation for preventing rubella and congenital rubella syndrome, this study measured the concentration of rubella-specific antibodies in Australian intramuscular (IM) and intravenous (IV) human immunoglobulin products suitable for post-exposure prophylaxis using a chemiluminescent immunoassay. The GMT ± GSD for the IM product was 19 ± 1.2 IU/mg (2980 ± 1.2 IU/mL). The GMT ± GSD for the IV product was 12 ± 1.5 IU/mg (729 ± 1.5 IU/mL). At present, Australian guidelines recommend offering non-immune pregnant women exposed to rubella 20 mL of intramuscular immunoglobulin within 72 hours of exposure. This equates to 42,160 IU of rubella antibodies if the lowest titer obtained for the Australian IM product is considered. The same dose would be delivered by 176 mL of the Australian IV product at the lowest measured rubella-specific antibody titer.


Subject(s)
Antibodies, Viral/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Immunoglobulins, Intravenous/immunology , Rubella virus/immunology , Rubella/prevention & control , Australia , Female , Humans , Immunization, Passive , Immunoglobulin G/therapeutic use , Immunoglobulin M/therapeutic use , Post-Exposure Prophylaxis , Pregnancy , Rubella/therapy , Rubella Syndrome, Congenital/prevention & control
5.
Rev Chilena Infectol ; 33(2): 191-216, 2016 Apr.
Article in Spanish | MEDLINE | ID: mdl-27314998

ABSTRACT

There is a lot of bacterial, viral or parasite infections who are able to be transmitted vertically from the mother to the fetus or newborn which implicates an enormous risk for it. The TORCH acronym is used universally to refer to a fetus or newborn which presents clinical features compatible with a vertically acquired infection and allows a rational diagnostic and therapeutic approach. The traditional "TORCH test" is nowadays considered not appropriate and it has been replaced for specific test for specific pathogens under well defined circumstances. The present document reviews the general characteristics, epidemiology, pathogenesis, diagnostic and therapeutic options for the most frequently involved pathogens in the fetus or newborn with TORCH suspicion.


Subject(s)
Infant, Newborn, Diseases , Chagas Disease/congenital , Chagas Disease/diagnosis , Chagas Disease/therapy , Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Female , Fetus , Herpes Simplex/congenital , Herpes Simplex/diagnosis , Herpes Simplex/therapy , Humans , Infant, Newborn , Infant, Newborn, Diseases/microbiology , Infant, Newborn, Diseases/parasitology , Infant, Newborn, Diseases/virology , Male , Practice Guidelines as Topic , Pregnancy , Pregnancy Complications, Infectious/microbiology , Pregnancy Complications, Infectious/parasitology , Pregnancy Complications, Infectious/virology , Prenatal Diagnosis , Risk Factors , Rubella/congenital , Rubella/diagnosis , Rubella/therapy , Syndrome , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy
6.
Rev. chil. infectol ; 33(2): 191-216, abr. 2016. ilus, tab
Article in Spanish | LILACS | ID: lil-784870

ABSTRACT

There is a lot of bacterial, viral or parasite infections who are able to be transmitted vertically from the mother to the fetus or newborn which implicates an enormous risk for it. The TORCH acronym is used universally to refer to a fetus or newborn which presents clinical features compatible with a vertically acquired infection and allows a rational diagnostic and therapeutic approach. The traditional "TORCH test" is nowadays considered not appropriate and it has been replaced for specific test for specific pathogens under well defined circumstances. The present document reviews the general characteristics, epidemiology, pathogenesis, diagnostic and therapeutic options for the most frequently involved pathogens in the fetus or newborn with TORCH suspicion.


Existen numerosas infecciones bacterianas, virales y parasitarias que pueden transmitirse desde la madre al feto o recién nacido (RN) y que significan un riesgo para él. El acrónimo TORCH se utiliza en forma universal para caracterizar a aquel feto o RN que presenta un cuadro clínico compatible con una infección congénita y que permite un enfrentamiento racional, tanto diagnóstico como terapéutico. El concepto tradicional de realizar un "test de TORCH" sin consideraciones específicas a cada paciente, hoy en día se considera no adecuado y ha sido reemplazado por exámenes específicos para patógenos específicos bajo circunstancias bien definidas. El presente documento revisa las características generales, epidemiológicas, patogénicas, diagnósticas y terapéuticas de los patógenos más frecuentemente involucrados en el estudio de pacientes con sospecha de TORCH.


Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Infant, Newborn, Diseases/microbiology , Infant, Newborn, Diseases/parasitology , Infant, Newborn, Diseases/virology , Pregnancy Complications, Infectious/microbiology , Pregnancy Complications, Infectious/parasitology , Pregnancy Complications, Infectious/virology , Prenatal Diagnosis , Rubella/congenital , Rubella/diagnosis , Rubella/therapy , Syndrome , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy , Risk Factors , Chagas Disease/congenital , Chagas Disease/diagnosis , Chagas Disease/therapy , Practice Guidelines as Topic , Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Fetus , Herpes Simplex/congenital , Herpes Simplex/diagnosis , Herpes Simplex/therapy
7.
J Pediatr Health Care ; 30(2): 173-82; quiz 183-4, 2016.
Article in English | MEDLINE | ID: mdl-26896379

ABSTRACT

Because some parents are choosing to not vaccinate or only partially vaccinate their children, vaccine-preventable diseases that once were rarely seen in pediatric practice must now be considered part of the differential diagnosis when caring for these children. Measles, mumps, varicella, meningococcal disease, pertussis, and influenza are reviewed. Recommendations for prevention and treatment of these vaccine-preventable diseases are discussed.


Subject(s)
Chickenpox/therapy , Influenza, Human/therapy , Measles/therapy , Mumps/therapy , Post-Exposure Prophylaxis/methods , Rubella/therapy , Vaccines/immunology , Whooping Cough/therapy , Chickenpox/epidemiology , Health Knowledge, Attitudes, Practice , Humans , Influenza, Human/epidemiology , Measles/epidemiology , Mumps/epidemiology , Rubella/epidemiology , Sentinel Surveillance , United States/epidemiology , Vaccination/statistics & numerical data , Whooping Cough/epidemiology
8.
Pediatr Emerg Med Pract ; 13(12): e1-e2, 2016 12 22.
Article in English | MEDLINE | ID: mdl-28745854

ABSTRACT

Vaccine-preventable diseases such as measles, mumps, rubella, and varicella continue to plague children and adults worldwide. Although public health programs have helped decrease the prevalence and sequelae of these diseases, outbreaks still occur. To limit the spread of these diseases, emergency clinicians must be able to readily identify the characteristic presentations of the rashes associated with measles, rubella, and varicella, as well as the common presenting features associated with mumps. Diagnostic laboratory studies are not usually necessary, as a complete history and physical examination usually lead to an accurate diagnosis. Treatment for these vaccine-preventable diseases usually consists of supportive care, but, in some cases, severe complications and death may occur. This issue provides a review of the clinical features, differential diagnoses, potential complications, and treatment options for measles, mumps, rubella, and varicella. [Points & Pearls is a digest of Pediatric Emergency Medicine Practice].


Subject(s)
Chickenpox , Measles , Mumps , Rubella , Vaccines, Combined , Chickenpox/diagnosis , Chickenpox/prevention & control , Chickenpox/therapy , Chickenpox Vaccine , Child , Humans , Measles/diagnosis , Measles/prevention & control , Measles-Mumps-Rubella Vaccine , Mumps/diagnosis , Mumps/prevention & control , Mumps/therapy , Rubella/diagnosis , Rubella/prevention & control , Rubella/therapy
9.
J Child Neurol ; 29(1): 49-53, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23275435

ABSTRACT

We to report clinical biological and radiologic features of rubella encephalitis in childhood and assess its prognostic impact. Our retrospective study was conducted in an intensive care unit of a university hospital in Sfax, Tunisia. Twenty-one children (age range, 1-15 years) were included. Median age was 9 years (lower and upper quartiles, 7-11 years). On admission, generalized maculopapular eruption was found in 17 cases (81%). Median Glasgow Coma Scale score was 7 (lower and upper quartiles, 7-8). Twenty patients (95.2%) experienced at least 1 episode of seizures. Sixteen patients (76.2%) developed a status epilepticus. The result for enzyme-linked immunosorbent assay detecting anti-rubella immunoglobulin (M) was positive in the serum and in the cerebrospinal fluid samples for all our patients. Magnetic resonance imaging (MRI) of the brain was performed on admission for 3 patients (14.3%) and within a median of 4 days (lower and upper quartiles, 2-6 days) for 8 patients. The test was normal in 6 cases. Two deaths were recorded (9.5%). Survivors had no neurological sequelae 6 months after intensive care unit discharge.


Subject(s)
Encephalitis, Viral , Rubella , Treatment Outcome , Acyclovir/therapeutic use , Adolescent , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antibodies, Viral/cerebrospinal fluid , Antiviral Agents/therapeutic use , Brain/pathology , Brain/virology , Cefotaxime/therapeutic use , Child , Child, Preschool , Dexamethasone/therapeutic use , Encephalitis, Viral/diagnosis , Encephalitis, Viral/etiology , Encephalitis, Viral/therapy , Female , Follow-Up Studies , Humans , Infant , Intensive Care Units , Male , Retrospective Studies , Rubella/complications , Rubella/diagnosis , Rubella/therapy , Tunisia
10.
Ann Biol Clin (Paris) ; 71: 5-18, 2013 Nov.
Article in French | MEDLINE | ID: mdl-24235323

ABSTRACT

Some infections are considered as feared risks during pregnancy. These infections may lead to severe damage of the fetus or the newborn depending on the infectious agent and the term of pregnancy where the infection occurred. Antenatal screening (in France it concerns toxoplasmosis, rubella, syphilis and hepatitis B) play an important role in prevention and management of vertically transmissible infections. However, biological diagnosis is also essential when maternal/neo-natal clinical symptoms or abnormal ultrasound findings are observed. In this article we chose to focus on rubella, varicella, syphilis, toxoplasmosis, hepatitis B and cytomegalovirus and parvovirus infections.


Subject(s)
Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/therapy , Chickenpox/diagnosis , Chickenpox/therapy , Chickenpox/transmission , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Cytomegalovirus Infections/transmission , Female , Fetal Diseases/diagnosis , Fetal Diseases/therapy , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/prevention & control , Parvoviridae Infections/diagnosis , Parvoviridae Infections/therapy , Parvoviridae Infections/transmission , Pregnancy , Rubella/diagnosis , Rubella/therapy , Rubella/transmission , Toxoplasmosis/diagnosis , Toxoplasmosis/therapy , Toxoplasmosis/transmission
12.
Indian J Pediatr ; 78(1): 88-95, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20953849

ABSTRACT

Infections acquired in utero or in the immediate post-natal period play a prominent role in perinatal and childhood morbidity. The TORCH constellation continues to be popular among perinatologists and paediatricians, although its limitations are increasingly known. A host of new organisms are now considered to be perpetrators of congenital and perinatal infections, and a diverse range of diagnostic tests are now available for confirming infection in the infant. In general, the collective TORCH serological panel has low diagnostic yield; instead individual tests ordered according to clinical presentation can contribute better towards appropriate diagnosis. This review captures the essence of established congenital infections such as cytomegalovirus, rubella, toxoplasmosis, syphilis and herpes simplex virus, as well as more recent entrants such as HIV and hepatitis B infection, varicella and tuberculosis. Selective screening of the mother and newborn, encouraging good personal hygiene and universal immunization are some measures that can contribute towards decreasing the incidence and morbidity of congenital and perinatal infections.


Subject(s)
Cytomegalovirus Infections/congenital , Herpes Simplex/congenital , Infant, Newborn, Diseases/microbiology , Rubella/congenital , Toxoplasmosis, Congenital , Toxoplasmosis , Abbreviations as Topic , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Herpes Simplex/diagnosis , Herpes Simplex/therapy , Humans , Infant, Newborn , Infant, Newborn, Diseases/diagnosis , Infant, Newborn, Diseases/therapy , Rubella/diagnosis , Rubella/therapy , Toxoplasmosis/diagnosis , Toxoplasmosis/therapy , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy
13.
Surv Ophthalmol ; 53(2): 95-111, 2008.
Article in English | MEDLINE | ID: mdl-18348876

ABSTRACT

Intrauterine infections are important causes of childhood blindness in both developed and developing countries. Chorioretinal scars are the most characteristic eye manifestation of a congenital or prenatal infection. The various ocular manifestations of congenital infections, summarized by the mnemonic TORCH, and recent additions to the "other" category (lymphocytic choriomeningitis virus and West Nile virus) are discussed.


Subject(s)
Eye Infections/congenital , Pregnancy Complications, Infectious , Adult , Chickenpox/congenital , Chickenpox/diagnosis , Chickenpox/therapy , Cytomegalovirus Infections/congenital , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Eye Infections/diagnosis , Eye Infections/therapy , Female , Herpes Simplex/congenital , Herpes Simplex/diagnosis , Herpes Simplex/therapy , Humans , Infant, Newborn , Pregnancy , Rubella/congenital , Rubella/diagnosis , Rubella/therapy , Toxoplasmosis, Congenital/complications , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy
14.
Minerva Pediatr ; 60(1): 141-4, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18277373

ABSTRACT

Rubella is an important childhood disease that was historically widespread but is now very infrequent. It is an acute viral infection ordinarily characterized by mild constitutional symptoms. Complications are relatively uncommon in childhood. Encephalitis similar to that seen with measles occurs in about 1 in 6,000 cases. The severity is highly variable, and there is an overall mortality rate of 20%. Symptoms in survivors usually resolve within 1-3 week without neurologic sequelae. An 8.5-year-old boy presented with rubella encephalitis and status epilepticus. Five days before admission the patient had erythematous maculopapular rash on the face, spreading to the trunk and extremities. On the admission day, he had a generalized tonic-clonic seizure with loss of consciousness. Microscopic and cytologic examinations of cerebrospinal fluid showed nonspecific. Electro-encephalography (EEG) showed diffuse slowing. An enzyme linked immunosorbent assay (ELISA) revealed that rubella IgM antibody titer was positive in serum and in cerebrospinal fluid. One day later, the patient became conscious with normal physical condition. As a conclusion, it is possible to prevent the complications of rubella infection, especially the congenital rubella syndrome and encephalitis with a rapid and efficient vaccination program.


Subject(s)
Encephalitis, Viral/complications , Rubella/complications , Status Epilepticus/virology , Child , Encephalitis, Viral/diagnosis , Encephalitis, Viral/immunology , Encephalitis, Viral/therapy , Encephalitis, Viral/virology , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin M/blood , Immunoglobulin M/cerebrospinal fluid , Male , Rubella/diagnosis , Rubella/immunology , Rubella/therapy , Status Epilepticus/diagnosis , Status Epilepticus/immunology , Status Epilepticus/therapy , Treatment Outcome
16.
Clin Dermatol ; 25(2): 212-20, 2007.
Article in English | MEDLINE | ID: mdl-17350501

ABSTRACT

Viral exanthems are a common problem in tropical regions, particularly affecting children. Most exanthems are transient and harmless, but some are potentially very dangerous. Pregnant women and malnourished or immunocompromised infants carry the greatest risk of adverse outcome. In this article, parvovirus B19; dengue and yellow fever; West Nile, Barmah Forest, Marburg, and Ebola viruses, and human herpesviruses; asymmetric periflexural exanthema of childhood; measles; rubella; enteroviruses; Lassa fever; and South American hemorrhagic fevers will be discussed.


Subject(s)
Exanthema/virology , Virus Diseases/diagnosis , Alphavirus Infections/diagnosis , Alphavirus Infections/therapy , Erythema Infectiosum/diagnosis , Erythema Infectiosum/therapy , Exanthema/therapy , Hemorrhagic Fevers, Viral/diagnosis , Hemorrhagic Fevers, Viral/therapy , Herpesviridae Infections/diagnosis , Herpesviridae Infections/therapy , Humans , Measles/diagnosis , Measles/therapy , Rubella/diagnosis , Rubella/therapy , Tropical Climate , Virus Diseases/therapy , West Nile Fever/diagnosis , West Nile Fever/therapy , Yellow Fever/diagnosis , Yellow Fever/therapy
17.
Fetal Pediatr Pathol ; 24(3): 169-89, 2005.
Article in English | MEDLINE | ID: mdl-16338879

ABSTRACT

With the advent of vaccine protection for many diseases, many of today's practitioners have never seen cases of what were the common childhood diseases. If any of these diseases returns, there is a risk that the practitioner will not recognize it. This article tries to establish why the diseases may return and to describe the diseases with photographs.


Subject(s)
Chickenpox , Communicable Diseases , Erythema Infectiosum , Measles , Mumps , Rubella , Chickenpox/complications , Chickenpox/physiopathology , Chickenpox/therapy , Child , Child, Preschool , Communicable Diseases/complications , Communicable Diseases/physiopathology , Communicable Diseases/therapy , Erythema Infectiosum/complications , Erythema Infectiosum/physiopathology , Erythema Infectiosum/therapy , Humans , Measles/complications , Measles/physiopathology , Measles/therapy , Mumps/complications , Mumps/physiopathology , Mumps/therapy , Rubella/complications , Rubella/physiopathology , Rubella/therapy
20.
J. bras. med ; 86(6): 75-77, jun. 2004. tab
Article in Portuguese | LILACS | ID: lil-401020

ABSTRACT

Apesar da interrupção da gestação não ser ainda permitida em nosso país, por esta razão, o diagnóstico pré-natal da infecção pelo vírus da rubéola torna-se de suma importância para orientar os perinatologistas sobre as condições futuras do recém-nascido, proportionando melhores condições de atendimento neonatal


Subject(s)
Humans , Female , Pregnancy , Prenatal Diagnosis , Prenatal Exposure Delayed Effects , Rubella/diagnosis , Rubella/prevention & control , Rubella/therapy , Maternal Exposure/prevention & control , Prenatal Care
SELECTION OF CITATIONS
SEARCH DETAIL
...